Cat-scratch disease during anti-tumor necrosis factor-alpha therapy: case report and review of the literature

Int J Dermatol. 2014 Mar;53(3):e182-3. doi: 10.1111/j.1365-4632.2012.05679.x. Epub 2013 Apr 4.

Authors

Filipa Osório¹, Ana Pedrosa, Filomena Azevedo, Paulo Figueiredo, Sofia Magina

Affiliation

¹ Department of Dermatology and Venereology, Centro Hospitalar de São João EPE, Porto, PortugalDepartment of Infectious Diseases, Centro Hospitalar de São João EPE, Porto, PortugalDepartment of Pharmacology and Therapeutics, Faculty of Medicine of University of Porto, Porto, Portugal.

PMID: 23557494
DOI: 10.1111/j.1365-4632.2012.05679.x

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adalimumab
Adult
Animals
Anti-Inflammatory Agents / adverse effects
Antibodies, Monoclonal, Humanized / adverse effects*
Bartonella / isolation & purification*
Bartonella Infections / complications*
Bartonella Infections / diagnostic imaging
Cat-Scratch Disease / diagnostic imaging*
Cat-Scratch Disease / microbiology*
Cats
Humans
Male
Middle Aged
Psoriasis / drug therapy*
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Ultrasonography

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal, Humanized
Tumor Necrosis Factor-alpha
Adalimumab